Karmanos Cancer Institute Welcomes a New Talent to Oncology
Dr. Khalil Choucair specializes in cancers of the chest, including lung cancer.
DETROIT – The Barbara Ann Karmanos Cancer Institute is excited to announce the addition of Dr. Khalil Choucair, a medical oncologist who brings extensive expertise in thoracic oncology. Dr. Choucair has a passion for treating patients with cancers of the chest, particularly lung cancer, and will contribute to both the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams.
The Journey of Dr. Khalil Choucair
Dr. Choucair’s path to Karmanos began with his clinical fellowship in hematology and oncology at the same institution, where he excelled as chief fellow. During this time, he collaborated closely with leading oncologists and researchers, gaining valuable experience and insight into advanced cancer treatments. Since July 2025, he has been providing care at the Karmanos Cancer Center and at Karmanos Cancer Institute – Dearborn.
A Commitment to Advancing Cancer Care
Upon joining the team, Dr. Choucair expressed his enthusiasm for continuing his practice at Karmanos, stating, "Karmanos is an esteemed institution where some of the best minds are studying daily to find the best cancer therapies, some of which have already changed the way we treat cancer. Having the opportunity to continue my practice and research at Karmanos is a privilege." His dedication to improving treatments not only aims to aid patients in Michigan but also seeks to bring advancements to a global audience.
Expertise in Thoracic Oncology
As a member of the thoracic oncology team, Dr. Choucair will focus on a range of cancers, including esophageal cancer, mesothelioma, thymoma, and thymic carcinoma. His research interests are vast and include thoracic oncology biomarkers, therapies for small cell lung cancer (SCLC), precision oncology, immune therapies, and tumor agnostic treatments. Furthermore, he is an integral part of the Phase I clinical trials, exploring promising new drugs and therapies that have the potential for significant patient impact.
Building the Future of Cancer Research
Dr. George Yoo, chief medical officer at Karmanos Cancer Hospital, has observed Dr. Choucair's growth and contributions, emphasizing his commitment to thoracic diseases and innovative therapies. Dr. Choucair has also co-directed the Lung Cancer Symposium, an event that attracts healthcare professionals keen on learning about advancements in oncology.
In addition to his clinical role, Dr. Choucair is passionate about educating the next generation of cancer specialists. Since 2023, he has served on the advisory board of Karmanos' Office of Cancer Research, Training and Education Coordination. He also holds a position as a clinical assistant professor in the Department of Oncology at Wayne State University School of Medicine.
A Strong Academic Background
Dr. Choucair's academic journey includes a research fellowship in precision oncology at the Eleanor N. Dana Cancer Center. He earned his degrees from McGill University in Canada, achieving a Master of Science in Experimental Medicine focused on prognostic biomarker development. His medical training was completed at the American University of Beirut, followed by a residency at the University of Kansas, where he was chief resident for Research Development. Dr. Choucair has authored more than 30 peer-reviewed articles, further establishing his credibility in the field.
His active engagement with various professional societies, such as the American College of Physicians and the American Society of Clinical Oncology, highlights his dedication to ongoing education and collaboration within the oncology community.
Family at Karmanos Cancer Institute
Karmanos Cancer Institute prides itself on its rich history of providing exceptional cancer care and conducting innovative research. With a commitment to compassionate care, the institute is recognized nationally for its comprehensive cancer care and its designation as a comprehensive cancer center by the National Cancer Institute. The partnership with Wayne State University School of Medicine enhances its mission to define new standards of care while improving patient outcomes.
For individuals seeking information about cancer care or to request an appointment, Karmanos offers comprehensive resources through their website and dedicated support via phone.
Frequently Asked Questions
What is Dr. Khalil Choucair's specialty?
Dr. Khalil Choucair specializes in treating cancers of the chest, including lung cancer.
What teams will Dr. Choucair be part of at Karmanos?
He will be part of the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams.
What types of cancers does Dr. Choucair focus on?
His focus includes esophageal cancer, lung cancer, mesothelioma, thymoma, and thymic carcinoma.
What is the significance of Phase I clinical trials?
These trials explore new cancer drugs and therapies that may improve treatment options before FDA approval.
How can I learn more about cancer care at Karmanos?
You can visit Karmanos' website or call 1-800-KARMANOS for more information.
